Single-Cell Analysis Market Size, Share & Trends Analysis Report 2021-2028
Single-cell Analysis Industry Overview
The global single-cell analysis market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.0% from 2021 to 2028. An increase in investments and government funds deployed for research and development (R&D) in the field of medical diagnostics, availability of technically advanced products, and the rising adoption of single-cell analysis devices are some factors that can be attributed to the growth of the market.
Moreover, the advent of technology in single-cell amplification and manipulation techniques has led to the application of high throughput technologies in assays, thereby propelling revenue growth. In addition, the rapid development of microfluidic devices has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field.
Gather more insights about the market drivers, restrains and growth of the Global Single-cell Analysis market
Technological advancements in sequencing techniques are transforming the landscape of single-cell omics research activities, including transcriptomic, epigenomics, and genomics. Significant advancements in sequencing reproducibility coupled with declining costs have helped process a large number of samples.
Increasing demand for analytical tools and technological advancements has led to the introduction of high-throughput machinery in the market. Several innovations have led to the introduction of new features such as high sensitivity, accuracy, and efficacy by utilizing scarce samples. Thus, key players are investing a significant amount in the development of solutions leading to a lucrative opportunity for revenue generation in the near future.
The ongoing pandemic of COVID-19 has triggered the adoption of single-cell analysis methods in virology research. The researchers are using these techniques to understand the immune profiles of infected patients. For instance, in a study published in January 2021, researchers from China performed high-dimensional single-cell analysis to understand the peripheral immune response to the COVID-19 infection.
Browse through Grand View Research's Biotechnology Industry Research Reports.
- 3D Printed Drugs Market - The global 3D printed drugs market size was valued at USD 72.02 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.32% from 2022 to 2030. 3D printed drugs are prescriptions that are created using the 3D printing process to give individuals safe and effective tailored medications. These medications have a unitary porous architecture that disperses easily in the mouth, eliminating the need to swallow high-dose medications whole. It allows manufacturers to modify the size, look, form, and rate of distribution of a wide range of drugs with ease.
- Immunoprotein Diagnostic Testing Market - The global immunoprotein diagnostic testing market size to be valued at USD 10.3 billion by 2025 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% during the forecast period. Increase in prevalence of chronic diseases has led to growth of market. High prevalence of chronic disorders, such as infectious diseases, cancer, cardiovascular disease, obesity, type 2 diabetes, and rheumatoid arthritis has led to growth of immunoprotein diagnostic testing products.
Single-cell Analysis Market Segmentation
Grand View Research has segmented the global single-cell analysis market on the basis of product, application, workflow, end-use, and region:
Single Cell Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)
- Consumables
- Reagents
- Assay Kits
- Instruments
- Microscope
- Hemocytometers
- Flow Cytometers
- NGS Systems
- PCR
- High Content Screening Systems
- Cell Microarrays
- Single Live Cell Imaging
- Automated Cell Counters
Single Cell Analysis Application Outlook (Revenue, USD Million, 2017 - 2028)
- Cancer
- Immunology
- Neurology
- Stem cell
- Non-invasive prenatal diagnosis
- In-vitro fertilization
- Others
Single Cell Analysis Workflow Outlook (Revenue, USD Million, 2017 - 2028)
- Single-cell isolation & Library Preparation
- Downstream Analysis
- Data Analysis
Single Cell Analysis End-use Outlook (Revenue, USD Million, 2017 - 2028)
- Academic & Research Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Others
Single Cell Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Market Share Insights
- February 2021: SeqWell Inc. launched plexWell Single Cell Rapid Kit for single-cell RNA sequencing. It is used for the simplified preparation of NGS libraries.
- February 2021: for the commercialization of its products to expand its presence outside the U.S. Such company initiatives are expected to intensify market competition.
Key Companies profiled:
Some prominent players in the global Single-cell Analysis market include
- Thermo Fisher Scientific Inc.
- QIAGEN NV
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Merck Millipore
- Becton
- Dickinson & Company
- Fluidigm Corporation
- 10x Genomics, Inc.
- BGI
- Novogene Corporation
Order a free sample PDF of the Single-cell Analysis Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment